Dermapharm Holding (Germany) Analysis
| DMP Stock | 34.30 0.30 0.87% |
Dermapharm Holding SE is overvalued with Real Value of 29.42 and Hype Value of 34.3. The main objective of Dermapharm Holding stock analysis is to determine its intrinsic value, which is an estimate of what Dermapharm Holding SE is worth, separate from its market price. There are two main types of Dermapharm Holding's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Dermapharm Holding's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Dermapharm Holding's stock to identify patterns and trends that may indicate its future price movements.
The Dermapharm Holding stock is traded in Germany on XETRA Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Dermapharm Holding is usually not traded on Good Friday, Easter Monday, International Workers ' Day, Christmas Day, Boxing Day, New Year 's Day. Dermapharm Stock trading window is adjusted to Europe/Berlin timezone.
Dermapharm |
Dermapharm Stock Analysis Notes
About 65.0% of the company shares are held by company insiders. The book value of Dermapharm Holding was currently reported as 9.36. The company last dividend was issued on the 2nd of June 2022. To learn more about Dermapharm Holding SE call HansGeorge Feldmeier at 49 89 6 41 86 0 or check out https://www.dermapharm.de.Dermapharm Holding Investment Alerts
| Dermapharm Holding generated a negative expected return over the last 90 days | |
| About 65.0% of the company shares are held by company insiders |
Dermapharm Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dermapharm Holding's market, we take the total number of its shares issued and multiply it by Dermapharm Holding's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Dermapharm Profitablity
Dermapharm Holding's profitability indicators refer to fundamental financial ratios that showcase Dermapharm Holding's ability to generate income relative to its revenue or operating costs. If, let's say, Dermapharm Holding is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Dermapharm Holding's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Dermapharm Holding's profitability requires more research than a typical breakdown of Dermapharm Holding's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Technical Drivers
As of the 21st of July, Dermapharm Holding shows the Variance of 3.25, standard deviation of 1.8, and Mean Deviation of 1.11. Dermapharm Holding technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Dermapharm Holding Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Dermapharm Holding for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Dermapharm Holding short-term fluctuations and highlight longer-term trends or cycles.
Dermapharm Holding Outstanding Bonds
Dermapharm Holding issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dermapharm Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dermapharm bonds can be classified according to their maturity, which is the date when Dermapharm Holding SE has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Dermapharm Holding Predictive Daily Indicators
Dermapharm Holding intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dermapharm Holding stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Dermapharm Holding Forecast Models
Dermapharm Holding's time-series forecasting models are one of many Dermapharm Holding's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dermapharm Holding's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Dermapharm Holding to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Additional Tools for Dermapharm Stock Analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.